You haven't noticed RAP are finally gaining traction for ResAppDx-EU revenue which even you know is massive after you previously invested in this revolutionary and disruptive medical device for respiratory consultation (might be why Pfizer decided to make their move after Q4's result and continue growth last quarter if they are serious about entering the digital medical market) and RAP haven't even broken into the market for chronic respiratory management of Asthma (for all age demographic) and COPD (for adult).
- Forums
- ASX - By Stock
- RAP
- NO-Vote support statement - draft 3
NO-Vote support statement - draft 3, page-30
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
|
|||||
Last
20.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $176.2M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
RAP (ASX) Chart |
Day chart unavailable
The Watchlist
MTL
MANTLE MINERALS LIMITED
Nick Poll, Executive Director
Nick Poll
Executive Director
SPONSORED BY The Market Online